This study involved 80 subjects. They received either one gram twice daily of BioCell Collagen or a placebo for 70 days. The treatment group experienced a significant improvement. All primary endpoint were met for statistical significance. The percentage of the subjects who experienced at least 30% improvement was 40% in the BioCell Collagen group and only 3% in the placebo. BioCell Collagen was well tolerated by the subjects in the clinical trial.
According to study investigator Alexander G. Schauss, PhD, FACN, Senior Director of AIBMR Life Sciences:
“This was a well-designed study published by one of the most recognized scientific journals in the world. We are pleased that results build on the substantial body of evidence indicating BioCell Collagen’s potential to make a difference in people’s lives.”
